Role of eIF3f in Pancreatic Cancer
eIF3f 在胰腺癌中的作用
基本信息
- 批准号:7609190
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesApoptosisApoptoticBindingBiological MarkersCaenorhabditis elegansCancer EtiologyCell ProliferationCessation of lifeComplexDataDetectionDevelopmentDrosophila melanogasterDuctal Epithelial CellEarly DiagnosisEctopic ExpressionEmbryoEtiologyEukaryotic Initiation Factor-3Figs - dietaryGenesGoalsHeterogeneous-Nuclear Ribonucleoprotein KHumanIn VitroLeadMalignant neoplasm of pancreasMolecularMolecular TargetMouse-ear CressMusNeoplastic Cell TransformationPancreasPathway interactionsPilot ProjectsPlayProtein BiosynthesisProteinsQuantum DotsRegulationRibonucleoproteinsRibosomal RNARibosomesRoleSCID MiceSignal PathwaySpecimenStagingStimulusSurvival RateTechnologyTissue MicroarrayTranslationsXenograft procedurecancer cellcaspase-3cell growthcell transformationhuman AKAP13 proteinin vivoknock-downmouse modelnovelnovel diagnosticsoverexpressionpancreatic neoplasmprotein complexpublic health relevancesmall hairpin RNAtherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Regulation of protein synthesis is fundamentally important for the control of cell growth and proliferation. The eukaryotic initiation factor 3 (eIF3) is a multi-protein complex that plays an important role in translation. Deletion of certain eIF3 subunit is embryonic lethal in mouse. eIF3f is the p47 subunit of eIF3 complex and is highly conserved in Drosophila melanogaster, C. elegans, and Arabidopsis thaliana. This pilot project investigates the hypothesis that decreased eIF3f expression contributes to pancreatic cancer development by deregulating translation and apoptosis. The expression of eIF3f is significantly decreased in pancreatic cancer. Loss of eIF3f gene allele was observed in pancreatic cancer specimens. eIF3f was also shown to be a negative regulator of translation. Ectopic expression of eIF3f inhibits translation, cell proliferation and induces apoptosis in pancreatic cancer cells. However, no one has studied the direct role of eIF3f in pancreatic neoplasm. Pancreatic cancer has a five year survival rate under 5% because of late detection. Our long term goal is to develop novel biomarkers for early diagnosis and to identify new molecular targets for treatment of pancreatic cancer. To address our hypothesis, the following specific aims will be pursued: (1) To determine if decreased eIF3f contributes to pancreatic neoplastic transformation in vitro and in vivo. eIF3f expression will be knocked down using eIF3f shRNA lentiviral construct in immortal normal human pancreatic ductal epithelial cells to assess the ability of eIF3f to transform these cells in vitro and in the xenograft SCID mouse model. Quantitative immunolabeling analysis of eIF3f protein will be performed using novel Quantum Dot technology on tissue microarrays to define the expression of eIF3f in different stages of pancreatic cancer. (2) To characterize the molecular mechanism by which eIF3f inhibits translation and induces apoptosis. The function of eIF3f as a regulatory non-core subunit of eIF3 is not known. Our preliminary data suggest that eIF3f is a negative regulator of translation. Overexpression of eIF3f leads to reduced ribosomes and rRNA degradation. In this aim, we will investigate the molecular mechanism by which eIF3f regulates rRNA degradation, translation and apoptosis. This proposal will contribute to the exploration of novel molecular pathways and better understanding of the etiology of pancreatic cancer. Characterization of this important new signaling pathway will lead to identification of new biomarkers and therapeutic targets for pancreatic cancer. PUBLIC HEALTH RELEVANCE: Role of eIF3f in Pancreatic Cancer. Pancreatic cancer is the fourth leading cause of cancer death. This proposal will contribute to the exploration of novel molecular pathways and better understanding of the etiology of pancreatic cancer. Characterization of this important new signaling pathway will lead to identification of new diagnostic biomarkers and therapeutic targets for pancreatic cancer.
描述(由申请人提供):调节蛋白质合成对控制细胞生长和增殖至关重要。真核起始因子3 (eIF3)是一种多蛋白复合物,在翻译过程中起重要作用。某些eIF3亚基的缺失在小鼠胚胎中具有致死性。eIF3f是eIF3复合物的p47亚基,在黑腹果蝇、秀丽隐杆线虫和拟南芥中高度保守。该试点项目研究了eIF3f表达降低通过解除翻译和细胞凋亡调控来促进胰腺癌发展的假设。eIF3f在胰腺癌中的表达明显降低。胰腺癌标本中eIF3f基因等位基因缺失。eIF3f也被证明是翻译的负调节因子。eIF3f异位表达抑制胰腺癌细胞翻译、细胞增殖和诱导凋亡。然而,没有人研究过eIF3f在胰腺肿瘤中的直接作用。由于发现较晚,胰腺癌的5年生存率低于5%。我们的长期目标是开发用于早期诊断的新型生物标志物,并确定治疗胰腺癌的新分子靶点。为了解决我们的假设,我们将追求以下具体目标:(1)确定体外和体内eIF3f的减少是否有助于胰腺肿瘤转化。利用eIF3f shRNA慢病毒构建体在永生的正常人胰腺导管上皮细胞中敲除eIF3f的表达,以评估eIF3f在体外和异种移植SCID小鼠模型中转化这些细胞的能力。eIF3f蛋白的定量免疫标记分析将使用组织微阵列上的新型量子点技术来确定eIF3f在不同阶段胰腺癌中的表达。(2)研究eIF3f抑制翻译并诱导细胞凋亡的分子机制。eIF3f作为eIF3的调控非核心亚基的功能尚不清楚。我们的初步数据表明eIF3f是翻译的负调控因子。过表达eIF3f导致核糖体减少和rRNA降解。为此,我们将研究eIF3f调控rRNA降解、翻译和凋亡的分子机制。这一建议将有助于探索新的分子途径和更好地了解胰腺癌的病因。表征这一重要的新信号通路将导致胰腺癌新的生物标志物和治疗靶点的鉴定。公共卫生相关性:eIF3f在胰腺癌中的作用胰腺癌是癌症死亡的第四大原因。这一建议将有助于探索新的分子途径和更好地了解胰腺癌的病因。表征这一重要的新信号通路将导致胰腺癌新的诊断生物标志物和治疗靶点的鉴定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiaqi Shi其他文献
Jiaqi Shi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiaqi Shi', 18)}}的其他基金
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
定义表观遗传信号重塑胰腺肿瘤微环境
- 批准号:
10666682 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
定义表观遗传信号重塑胰腺肿瘤微环境
- 批准号:
10514158 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Linking epigenetic regulation and TGF-β signaling in pancreatic cancer
连接胰腺癌中的表观遗传调控和 TGF-β 信号传导
- 批准号:
10198867 - 财政年份:2018
- 资助金额:
$ 7.55万 - 项目类别:
Linking epigenetic regulation and TGF-β signaling in pancreatic cancer
连接胰腺癌中的表观遗传调控和 TGF-β 信号传导
- 批准号:
9977982 - 财政年份:2018
- 资助金额:
$ 7.55万 - 项目类别:
Translational Control by eIF3f in Pancreatic Cancer
eIF3f 在胰腺癌中的翻译控制
- 批准号:
8090193 - 财政年份:2011
- 资助金额:
$ 7.55万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别: